GEE Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 2, 2025, 4:18 am

Competitors of GEE Ltd

All Competitor Stocks of GEE Ltd

Quarterly Result

Last Updated: August 19, 2025, 2:45 pm

Below is a detailed analysis of the quarterly data for GEE Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 79.18 Cr.. The value appears to be declining and may need further review. It has decreased from 87.97 Cr. (Mar 2025) to 79.18 Cr., marking a decrease of 8.79 Cr..
• For Expenses, as of Jun 2025, the value is 74.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 104.12 Cr. (Mar 2025) to 74.64 Cr., marking a decrease of 29.48 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.54 Cr.. The value appears strong and on an upward trend. It has increased from -16.15 Cr. (Mar 2025) to 4.54 Cr., marking an increase of 20.69 Cr..
• For OPM %, as of Jun 2025, the value is 5.73%. The value appears strong and on an upward trend. It has increased from -18.36% (Mar 2025) to 5.73%, marking an increase of 24.09%.
• For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 0.14 Cr..
• For Interest, as of Jun 2025, the value is 2.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.42 Cr. (Mar 2025) to 2.24 Cr., marking a decrease of 0.18 Cr..
• For Depreciation, as of Jun 2025, the value is 1.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.09 Cr. (Mar 2025) to 1.02 Cr., marking a decrease of 0.07 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.30 Cr.. The value appears strong and on an upward trend. It has increased from -19.78 Cr. (Mar 2025) to 1.30 Cr., marking an increase of 21.08 Cr..
• For Tax %, as of Jun 2025, the value is 25.38%. The value appears to be increasing, which may not be favorable. It has increased from -23.71% (Mar 2025) to 25.38%, marking an increase of 49.09%.
• For Net Profit, as of Jun 2025, the value is 0.98 Cr.. The value appears strong and on an upward trend. It has increased from -15.08 Cr. (Mar 2025) to 0.98 Cr., marking an increase of 16.06 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.38. The value appears strong and on an upward trend. It has increased from -5.80 (Mar 2025) to 0.38, marking an increase of 6.18.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:16 am

Growth

Last Updated: September 5, 2025, 3:31 pm

Balance Sheet

Last Updated: August 11, 2025, 4:02 pm

Below is a detailed analysis of the balance sheet data for GEE Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Reserves, as of Mar 2025, the value is 188.00 Cr.. The value appears to be declining and may need further review. It has decreased from 199.00 Cr. (Mar 2024) to 188.00 Cr., marking a decrease of 11.00 Cr..
• For Borrowings, as of Mar 2025, the value is 81.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 82.00 Cr. (Mar 2024) to 81.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 36.00 Cr.. The value appears to be improving (decreasing). It has decreased from 38.00 Cr. (Mar 2024) to 36.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 311.00 Cr.. The value appears to be improving (decreasing). It has decreased from 324.00 Cr. (Mar 2024) to 311.00 Cr., marking a decrease of 13.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 167.00 Cr.. The value appears to be declining and may need further review. It has decreased from 171.00 Cr. (Mar 2024) to 167.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 152.00 Cr. (Mar 2024) to 144.00 Cr., marking a decrease of 8.00 Cr..
• For Total Assets, as of Mar 2025, the value is 311.00 Cr.. The value appears to be declining and may need further review. It has decreased from 324.00 Cr. (Mar 2024) to 311.00 Cr., marking a decrease of 13.00 Cr..

Notably, the Reserves (188.00 Cr.) exceed the Borrowings (81.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for GEE Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -3.56. This value is below the healthy minimum of 5. It has decreased from 4.95 (Mar 24) to -3.56, marking a decrease of 8.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is -3.56. This value is below the healthy minimum of 5. It has decreased from 4.95 (Mar 24) to -3.56, marking a decrease of 8.51.
• For Cash EPS (Rs.), as of Mar 25, the value is -1.96. This value is below the healthy minimum of 3. It has decreased from 6.49 (Mar 24) to -1.96, marking a decrease of 8.45.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 74.47. It has increased from 50.52 (Mar 24) to 74.47, marking an increase of 23.95.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 74.47. It has decreased from 78.61 (Mar 24) to 74.47, marking a decrease of 4.14.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 128.45. It has decreased from 142.04 (Mar 24) to 128.45, marking a decrease of 13.59.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 2. It has decreased from 11.64 (Mar 24) to 0.42, marking a decrease of 11.22.
• For PBIT / Share (Rs.), as of Mar 25, the value is -1.18. This value is below the healthy minimum of 0. It has decreased from 10.09 (Mar 24) to -1.18, marking a decrease of 11.27.
• For PBT / Share (Rs.), as of Mar 25, the value is -4.60. This value is below the healthy minimum of 0. It has decreased from 6.95 (Mar 24) to -4.60, marking a decrease of 11.55.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -3.56. This value is below the healthy minimum of 2. It has decreased from 4.95 (Mar 24) to -3.56, marking a decrease of 8.51.
• For PBDIT Margin (%), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 10. It has decreased from 8.19 (Mar 24) to 0.32, marking a decrease of 7.87.
• For PBIT Margin (%), as of Mar 25, the value is -0.91. This value is below the healthy minimum of 10. It has decreased from 7.10 (Mar 24) to -0.91, marking a decrease of 8.01.
• For PBT Margin (%), as of Mar 25, the value is -3.58. This value is below the healthy minimum of 10. It has decreased from 4.89 (Mar 24) to -3.58, marking a decrease of 8.47.
• For Net Profit Margin (%), as of Mar 25, the value is -2.76. This value is below the healthy minimum of 5. It has decreased from 3.48 (Mar 24) to -2.76, marking a decrease of 6.24.
• For Return on Networth / Equity (%), as of Mar 25, the value is -4.77. This value is below the healthy minimum of 15. It has decreased from 9.79 (Mar 24) to -4.77, marking a decrease of 14.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is -1.49. This value is below the healthy minimum of 10. It has decreased from 12.04 (Mar 24) to -1.49, marking a decrease of 13.53.
• For Return On Assets (%), as of Mar 25, the value is -2.96. This value is below the healthy minimum of 5. It has decreased from 3.97 (Mar 24) to -2.96, marking a decrease of 6.93.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.05, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.42, marking a decrease of 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.05. It has decreased from 1.15 (Mar 24) to 1.05, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.38 (Mar 24) to 1.27, marking a decrease of 0.11.
• For Quick Ratio (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.53.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.95. This value is below the healthy minimum of 4. It has increased from 3.28 (Mar 24) to 3.95, marking an increase of 0.67.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 3. It has decreased from 3.70 (Mar 24) to 0.12, marking a decrease of 3.58.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.03. This value is below the healthy minimum of 3. It has decreased from 2.57 (Mar 24) to -0.03, marking a decrease of 2.60.
• For Enterprise Value (Cr.), as of Mar 25, the value is 378.89. It has decreased from 421.33 (Mar 24) to 378.89, marking a decrease of 42.44.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.13. This value is within the healthy range. It has decreased from 1.14 (Mar 24) to 1.13, marking a decrease of 0.01.
• For EV / EBITDA (X), as of Mar 25, the value is 344.11. This value exceeds the healthy maximum of 15. It has increased from 13.93 (Mar 24) to 344.11, marking an increase of 330.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.90, marking a decrease of 0.02.
• For Price / BV (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has decreased from 2.59 (Mar 24) to 1.56, marking a decrease of 1.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.90, marking a decrease of 0.02.
• For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to -0.03, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness